drugset / Trial / NCT00355667
Comparison of Long- and Short-acting Diuretics in Congestive Heart Failure
Phase 4
Completed
320 enrolled
Hyogo Medical University
Ministry of Health, Labour and Welfare, Japan · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare therapeutic effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting one, in patients with heart failure, and to test our hypothesis that long-acting diuretics are superior to short-acting types in heart failure.
Timeline
- Start
- 2006-06
- Primary completion
- 2010-08
- Completion
- 2010-08
Publications
- Background Yoshida J, Yamamoto K, Mano T, Sakata Y, Nishio M, Ohtani T, Hori M, Miwa T, Masuyama T. Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats. Cardiovasc Res. 2005 Oct 1;68(1):118-27. doi: 10.1016/j.cardiores.2005.05.023.
- Background J-MELODIC Program Committee. Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC). Circ J. 2007 Jul;71(7):1137-40. doi: 10.1253/circj.71.1137.
- Results Masuyama T, Tsujino T, Origasa H, Yamamoto K, Akasaka T, Hirano Y, Ohte N, Daimon T, Nakatani S, Ito H. Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure. Circ J. 2012;76(4):833-42. doi: 10.1253/circj.cj-11-1500.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Furosemide | Other / unclassified | 20 mg | — |
| Comparator | Furosemide | Other / unclassified | 40 mg | — |
| Comparator | azosemide | Small molecule | 30 mg | — |
| Comparator | azosemide | Small molecule | 60 mg | — |